Vendome Acquisition Corporation I Class A Ordinary Shares Market Cap ($206.80 Million)
Market Cap & Net Worth: Vendome Acquisition Corporation I Class A Ordinary Shares (VNME)
Vendome Acquisition Corporation I Class A Ordinary Shares market cap. Vendome Acquisition Corporation I Class A Ordinary Shares (NASDAQ:VNME) has a market capitalization of $206.80 Million ($206.80 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16228 globally and #3874 in its home market, demonstrating a 0.29% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vendome Acquisition Corporation I Class A Ordinary Shares's stock price $10.34 by its total outstanding shares 20000000 (20.00 Million). Also see cash efficiency ratio of Vendome Acquisition Corporation I Class for how efficiently the company converts equity into cash flow.
Vendome Acquisition Corporation I Class A Ordinary Shares Market Cap History (2025–2026)
Vendome Acquisition Corporation I Class A Ordinary Shares market cap history from 2025 to 2026. Data shows growth from $200.60 Million to $206.80 Million (0.00% CAGR). Check Vendome Acquisition Corporation I Class (VNME) stock price for real-time trading data and today's change.
Vendome Acquisition Corporation I Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vendome Acquisition Corporation I Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check VNME total equity to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of VNME by Market Capitalization
Companies near Vendome Acquisition Corporation I Class A Ordinary Shares in the global market cap rankings as of November 5, 2026. Also see Vendome Acquisition Corporation I Class balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Vendome Acquisition Corporation I Class A Ordinary Shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #5932 globally with a market cap of $2.02 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10662 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11112 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11515 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5932 | Twenty One Capital, Inc. | NYSE:XXI | $2.02 Billion | $5.83 |
| #10662 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.23 |
| #11112 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11515 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Market Capitalization of Vendome Acquisition Corporation I Class A Ordinary Shares (2025–2026)
Market capitalization of Vendome Acquisition Corporation I Class A Ordinary Shares from 2025 to today. Between 2025 and today, Vendome Acquisition Corporation I Class A Ordinary Shares's market cap moved from $200.60 Million to $ 206.80 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $206.80 Million | +3.09% |
| 2025 | $200.60 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Vendome Acquisition Corporation I Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $206.80 Million USD |
| MoneyControl | $206.80 Million USD |
| MarketWatch | $206.80 Million USD |
| marketcap.company | $206.80 Million USD |
| Reuters | $206.80 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vendome Acquisition Corporation I Class A Ordinary Shares
Vendome Acquisition Corporation I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Park City, Utah.